These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33433931)

  • 41. Don't neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia.
    Ucar İ; Koyuncu MB; Solmaz AA; Ugurludogan AC; Mercan S; Kucuk M; Unal T; Mazman S; Atilla E
    Transfus Clin Biol; 2023 Feb; 30(1):11-15. PubMed ID: 36028153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases.
    Graf J; Ingwersen J; Lepka K; Albrecht P; Hartung HP; Ringelstein M; Aktas O
    Acta Neurol Scand; 2019 Oct; 140(4):290-295. PubMed ID: 31269227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin.
    Kojima T; Hayashi S; Yokoyama I; Takagi H
    Transplantation; 1996 Sep; 62(5):559-62. PubMed ID: 8830815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature.
    Desborough MJ; Miller J; Thorpe SJ; Murphy MF; Misbah SA
    Transfus Med; 2014 Aug; 24(4):219-26. PubMed ID: 24164446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Severe intravenous immunoglobulin-induced hemolysis with pigment nephropathy managed with red cell exchange.
    Lasica M; Zantomio D
    J Clin Apher; 2016 Oct; 31(5):464-6. PubMed ID: 26297048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Insisting on intravenous polyvalent immunoglobulin therapy in polymyositis in spite of the occurrence of sever hemolytic anemia].
    Ballot-Brossier C; Mortelecque R; Sinègre M; Marceau A; Dauriat G; Courtois F
    Transfus Clin Biol; 2001 Apr; 8(2):94-9. PubMed ID: 11386046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement C3 deposition onto bacteria by neonatal serum is not enhanced after the infusion of intravenous immunoglobulin.
    Lassiter HA; Speranza MJ; Hall RT; Meade V; Christensen RD; Parker CJ
    J Perinatol; 1990 Mar; 10(1):27-31. PubMed ID: 2107285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Retrospective Observational Study of Adverse Reactions Associated With Intravenous Immunoglobulin Infusion.
    Kato H; Hayashi M; Ohashi W; Yamaguchi T; Tanaka S; Kozono A; Gao S; Katai A; Niwa R; Matsuo T; Ishiyama K; Ando T; Ogawa M; Nakayama T
    Front Immunol; 2021; 12():740517. PubMed ID: 34603326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Posttransplant immune-mediated hemolysis.
    Sokol RJ; Stamps R; Booker DJ; Scott FM; Laidlaw ST; Vandenberghe EA; Barker HF
    Transfusion; 2002 Feb; 42(2):198-204. PubMed ID: 11896335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG).
    Coghill J; Comeau T; Shea T; Braddy L; Bandarenko N; Afenyi-Annan A; Harvey D
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):786-8. PubMed ID: 16785068
    [No Abstract]   [Full Text] [Related]  

  • 53. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
    Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
    Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency.
    Kallenberg CG
    Clin Exp Immunol; 2007 Dec; 150(3):437-41. PubMed ID: 17956584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic changes in serum (1-3)-β-D-glucan caused by intravenous immunoglobulin infusion: A prospective study.
    Wan X; Liufu R; Liu R; Chen Y; Li S; Li Y; Peng J; Weng L; Du B
    Diagn Microbiol Infect Dis; 2024 Aug; 109(4):116328. PubMed ID: 38823207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study.
    Moulis G; Sailler L; Sommet A; Lapeyre-Mestre M; Montastruc JL;
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):314-9. PubMed ID: 21953992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of whole and fractionated intravenous immunoglobulin on complement in vitro.
    Mollnes TE; Andreassen IH; Høgåsen K; Hack CE; Harboe M
    Mol Immunol; 1997 Jul; 34(10):719-29. PubMed ID: 9430199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacovigilance study of a regional intravenous immunoglobulin (II): evaluation and comparison of an improved pharmaceutical form.
    Mahieu AC; Sisti AM; Joekes S; Manfredi MJ
    Allergol Immunopathol (Madr); 2006; 34(6):242-7. PubMed ID: 17173840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1.
    Lassiter HA; Robinson TW; Brown MS; Hall DC; Hill HR; Christensen RD
    J Perinatol; 1996; 16(5):346-51. PubMed ID: 8915932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.